Dysregulation of the EGF system signaling network participates in the pathogenesis of various diseases (diabetes, autoimmune, inflammatory, cardiovascular and nervous system disorders), as well as in cancer [37,38,39,41]. This evidence concerns the gene EGF and cancer.